GSA Capital Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$360K Sell
3,348
-780
-19% -$83.9K 0.03% 1149
2025
Q1
$416K Buy
4,128
+829
+25% +$83.5K 0.04% 926
2024
Q4
$295K Buy
+3,299
New +$295K 0.02% 1216
2022
Q3
Sell
-19,182
Closed -$715K 1534
2022
Q2
$715K Buy
+19,182
New +$715K 0.11% 291
2020
Q4
Sell
-7,531
Closed -$288K 1229
2020
Q3
$288K Sell
7,531
-144
-2% -$5.51K 0.05% 766
2020
Q2
$269K Buy
+7,675
New +$269K 0.15% 218
2020
Q1
Sell
-9,220
Closed -$417K 1083
2019
Q4
$417K Sell
9,220
-5,646
-38% -$255K 0.05% 787
2019
Q3
$605K Buy
+14,866
New +$605K 0.08% 433
2019
Q2
Sell
-15,955
Closed -$612K 1452
2019
Q1
$612K Sell
15,955
-686
-4% -$26.3K 0.06% 570
2018
Q4
$588K Buy
+16,641
New +$588K 0.07% 475
2018
Q3
Sell
-10,838
Closed -$354K 1640
2018
Q2
$354K Sell
10,838
-1,829
-14% -$59.7K 0.02% 1315
2018
Q1
$346K Sell
12,667
-90,193
-88% -$2.46M 0.02% 1251
2017
Q4
$2.55M Buy
+102,860
New +$2.55M 0.16% 136
2017
Q3
Sell
-12,513
Closed -$347K 1612
2017
Q2
$347K Buy
12,513
+2,247
+22% +$62.3K 0.02% 1199
2017
Q1
$255K Buy
+10,266
New +$255K 0.01% 1468
2016
Q4
Sell
-51,253
Closed -$1.22M 1756
2016
Q3
$1.22M Buy
51,253
+30,561
+148% +$727K 0.07% 496
2016
Q2
$484K Sell
20,692
-57,053
-73% -$1.33M 0.03% 1093
2016
Q1
$1.46M Sell
77,745
-29,407
-27% -$553K 0.09% 334
2015
Q4
$1.98M Buy
+107,152
New +$1.98M 0.1% 257
2015
Q3
Sell
-54,803
Closed -$970K 1754
2015
Q2
$970K Buy
54,803
+13,200
+32% +$234K 0.04% 928
2015
Q1
$738K Buy
+41,603
New +$738K 0.03% 1121
2014
Q4
Sell
-181,964
Closed -$2.15M 1708
2014
Q3
$2.15M Sell
181,964
-430,331
-70% -$5.08M 0.11% 177
2014
Q2
$7.82M Buy
612,295
+579,511
+1,768% +$7.4M 0.35% 26
2014
Q1
$443K Sell
32,784
-50,900
-61% -$688K 0.03% 868
2013
Q4
$1.01M Buy
83,684
+48,437
+137% +$582K 0.08% 348
2013
Q3
$414K Sell
35,247
-27,977
-44% -$329K 0.03% 919
2013
Q2
$586K Buy
+63,224
New +$586K 0.07% 459